-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Rapid Therapeutic Science Laboratories, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2014 to Q3 2022.
- Rapid Therapeutic Science Laboratories, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$227K, a 61.1% increase year-over-year.
- Rapid Therapeutic Science Laboratories, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$3.06M, a 39.8% decline year-over-year.
- Rapid Therapeutic Science Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$2.87M, a 39.8% decline from 2020.
- Rapid Therapeutic Science Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$2.05M, a 229% decline from 2019.
- Rapid Therapeutic Science Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$625K, a 79% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)